1-4 of 4
Yu Uemura
Close
Sort by
Journal Articles

Phase II Study of a JAK1/2 Inhibitor Ruxolitinib for Systemic Chronic Active Epstein-Barr Virus Disease: An Investigator-Initiated Trial

Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Norio Shimizu, Ryuji Koike, Ayako Arai
Journal: Blood
Blood (2022) 140 (Supplement 1): 6571–6572.
https://doi.org/10.1182/blood-2022-168565
Published: 2022
Journal Articles

The Plasma Level of IL-1β As a Biomarker of Angiopathy in Systemic Chronic Active EBV Infection

Ayaka Ohashi, Yu Uemura, Mayumi Yoshimori, Naomi Wada, Ken-Ichi Imadome, Kazuo Yudo, Takatoshi Koyama, Miwako Nishio, Ayako Arai
Journal: Blood
Blood (2021) 138 (Supplement 1): 4495.
https://doi.org/10.1182/blood-2021-149843
Published: 2021
Journal Articles

What Plasma Level of Interferon-γ Indicates in Systemic Chronic Active Epstein-Barr Virus Infection

Yu Uemura, Mayumi Yoshimori, Ayaka Ohashi, Tsuneaki Hirakawa, Naomi Wada, Ken-Ichi Imadome, Ayako Arai
Journal: Blood
Blood (2021) 138 (Supplement 1): 4529.
https://doi.org/10.1182/blood-2021-152285
Published: 2021
Journal Articles

Mantle Cell Lymphoma Is Associated with a Variable Number of PD-1-Positive Tumor Infiltrating T-Cells

Naoto Tomita, Naoya Nakamura, Haruka Ikoma, Masahiro Hoshikawa, Akiko Uchida, Yu Uemura, Kazuyuki Sato, Yuka Tsuruoka, Yuji Nishio, Manabu Matsunawa, Yoshinori Suzuki, Yasushi Isobe, Hirotaka Sakai, Masayuki Kato, Yasuyuki Inoue, Ikuo Miura
Journal: Blood
Blood (2016) 128 (22): 5317.
https://doi.org/10.1182/blood.V128.22.5317.5317
Published: 2016